Intro

This chapter explores the intricacies of vaccine efficacy, focusing on the Johnson & Johnson COVID-19 vaccine and its varied efficacy rates. It emphasizes the significance of clinical trial designs and diverse populations in interpreting these metrics amid evolving virus variants.